Editorial: Engineered Targeted Cancer Immunotherapies

Front Oncol. 2022 Jul 4:12:953175. doi: 10.3389/fonc.2022.953175. eCollection 2022.

Authors

Massimo Fantini¹, Roberto Bei²

Affiliations

¹ Precision Biologics, Inc., Bethesda, MD, United States.
² Department of Clinical Sciences and Translational Medicine, University of Rome "Tor Vergata", Rome, Italy.

No abstract available

Keywords: CAR-NK cells; CAR-T cells; antibody-dependent cell-mediated cytotoxicity; cancer immunotherapy; monoclonal antibodies.

Publication types

Editorial